JNJ Faces $32M Talc Verdict, Adding Legal Pressure

A Los Angeles jury has found Johnson & Johnson (NYSE:JNJ) and its subsidiaries liable in a talc trial linked to mesothelioma. The jury awarded US$32 million to the family of a woman whose fatal illness was tied to long-term use of the company’s talc-based baby powder.

Verdict Details

• Amount: US$32 million.
• Cause: Link between talc baby powder and mesothelioma.
• Defendants: Johnson & Johnson and its subsidiaries.

Company Response

Johnson & Johnson has not yet issued an official statement. The company has consistently denied any asbestos contamination in its talc products and continues to defend them in court.

Precedents and Context

This verdict is the latest in a long series of lawsuits against Johnson & Johnson over talc products. In recent years, the company has faced thousands of claims alleging that its baby powder causes cancer. Some courts have issued large awards, but many have been overturned or reduced on appeal.

Potential Financial Impact

While the $32 million award is relatively small compared to J&J’s annual revenue (over $80 billion), continued adverse verdicts could increase pressure on the company to seek a global settlement or change its legal strategy. Reputational damage may also affect consumer and investor confidence.